Beam Therapeutics Inc. (BEAM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Beam Therapeutics Inc.

    NASDAQ: BEAM · Real-Time Price · USD
    25.75
    0.16 (0.63%)
    At close: Oct 03, 2025, 3:59 PM
    25.73
    -0.08%
    After-hours: Oct 03, 2025, 07:42 PM EDT

    Beam Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.42 -15.85 -10.39 -14.99
    PEG Ratio
    		 -0.03 0.29 0.36 4.57
    PS Ratio
    		 32.14 5.56 44.95 98.73
    PB Ratio
    		 2.78 2.14 3.73 6.19
    P/FCF Ratio
    		 -5.73 -11.48 -103.63 -45.26
    P/OCF Ratio
    		 -5.88 -14.08 121.56 -77.24
    OCF/S Ratio
    		 -5.47 -0.39 0.37 -1.28
    Debt / Equity Ratio
    		 0.22 0.18 0.24 0.17
    Quick Ratio
    		 4.82 5.89 4.89 7.37
    Current Ratio
    		 4.82 5.89 4.89 4.52
    Asset Turnover
    		 0.06 0.26 0.05 0.04
    Interest Coverage
    		 n/a n/a -22.13 -43.61K
    Return on Equity
    		 -0.51 -0.14 -0.36 -0.41
    Return on Assets
    		 -0.34 -0.09 -0.2 -0.23
    Return on Invested Capital
    		 -0.44 -0.14 -0.3 -0.28
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 -0.16 0.63 0.68
    Net Profit Margin
    		 -5.93 -0.35 -4.33 -6.58
    Pretax Profit Margin
    		 -5.93 -0.35 -4.27 -7.15
    Operating Profit Margin
    		 -6.54 -0.47 -5.56 -7.57
    FCF Margin
    		 -5.61 -0.48 -0.43 -2.18
    EBITDA Margin
    		 -6.05 -0.41 -5.32 -7.57

    Add to Watchlist